Human IGF-1R/CD221 Assay ELISA Kit

Cat Num

70-EK1178

Product Name

Human IGF-1R/CD221 ELISA Kit

Customs Name

Human IGF-1R/CD221 ELISA Kit

Application

ELISA

Reactivity

Human

Assay Type

Sandwich ELISA

Suitable Sample Type

serum, plasma, cell culture supernates

Format

96-well strip plate

Storage

4℃ (unopened)standard stored at -20℃, others stored at 4℃ (opened)

Shipping Condition

4℃

Sample Volume

20 μl

Sensitivity

13.27 pg/ml

Standard Curve Range

218.75 - 14000 pg/ml

Spike Recovery Range

73 % - 113%

Mean Spike Recovery

0.91

CV of Intra plate

5.7 % - 9.7 %

CV of Inter plate

4.2 % - 9.2 %

Components

96-well polystyrene microplate coated with a monoclonal antibody against IGF-1R
Human IGF-1R Standard, lyophilized
IGF-1R Detect Antibody
Standard Diluent
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers

Describtion

This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human IGF-1R. The Human IGF-1R/CD221 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
The insulin-like growth factor 1 (IGF-1) receptor is a protein found on the surface of human cells. It is a transmembrane receptor that is activated by a hormone called insulin-like growth factor 1 (IGF-1) and by a related hormone called IGF-2. It belongs to the large class of tyrosine kinase receptors. This receptor mediates the effects of IGF-1, which is a polypeptide protein hormone similar in molecular structure to insulin. IGF-1 plays an important role in growth and continues to have anabolic effects in adults - meaning that it can induce hypertrophy of skeletal muscle and other target tissues. Mice lacking the IGF-1 receptor die late in development, and show a dramatic reduction in body mass, testifying to the strong growth-promoting effect of this receptor. Studies showed that the IGF-1R is implicated in several cancers, including breast, prostate, and lung cancers.sclerosis, psoriasis, inflammatory bowel disease, and asthma.
IL-17A expression is associated with many inflammatory diseases in humans, such as rheumatoid arthritis, multiple sclerosis, asthma, systemic lupus erythematosus, and allograft rejection. Expression of IL-17F is also linked with human inflammatory diseases, including asthma.